Autoimmune Hemolytic Anemia and Its Clinical Implication on Antiphospholipid Syndrome
Recruiting
N/A
Interventional Study
Anti Phospholipid Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 230 (estimated)
- Sponsor
- New Valley University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
AIHA is a heterogeneous autoimmune cytopenia with variable severity and significant morbidity. APS is defined by thrombosis and/or obstetric morbidity with persistent antiphospholipid antibodies (aPL).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged ≥18 years
* Patients with anemia consistant with hemolysis.
* Patient diagnosed with antiphospholipid syndrome.
* Informed consent obtained
Exclusion Criteria:
* Age less than 18 years.
* Other causes of anemia than autoimmune hemolysis.
Contacts